George Hill

873 total citations
21 papers, 645 citations indexed

About

George Hill is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, George Hill has authored 21 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in George Hill's work include Hepatitis C virus research (9 papers), HIV/AIDS drug development and treatment (4 papers) and Influenza Virus Research Studies (3 papers). George Hill is often cited by papers focused on Hepatitis C virus research (9 papers), HIV/AIDS drug development and treatment (4 papers) and Influenza Virus Research Studies (3 papers). George Hill collaborates with scholars based in United States, Switzerland and United Kingdom. George Hill's co-authors include Charles Oo, Penelope Ward, Albert Dorr, Isabel Nájera, M. Rodríguez‐Torres, Hugh Wiltshire, Tomáš Cihlář, Graham Cooksley, David Shaw and Carla Washington and has published in prestigious journals such as Hepatology, Journal of Hepatology and Heart.

In The Last Decade

George Hill

20 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Hill United States 12 431 285 193 173 67 21 645
Hwa-ping Feng United States 11 163 0.4× 181 0.6× 117 0.6× 245 1.4× 20 0.3× 38 573
Yeojin Park United States 13 207 0.5× 180 0.6× 251 1.3× 139 0.8× 29 0.4× 22 551
Gong Shen United States 11 167 0.4× 142 0.5× 349 1.8× 86 0.5× 12 0.2× 21 516
Gitanjali Subramanya United States 7 231 0.5× 166 0.6× 438 2.3× 114 0.7× 31 0.5× 8 793
Pascale Dehertogh Belgium 16 436 1.0× 437 1.5× 601 3.1× 183 1.1× 21 0.3× 19 1.1k
Daniel González de Requena Italy 18 247 0.6× 237 0.8× 742 3.8× 57 0.3× 25 0.4× 34 951
Steven Olsen United States 9 180 0.4× 38 0.1× 189 1.0× 58 0.3× 31 0.5× 12 365
Katia Alves United States 12 437 1.0× 399 1.4× 353 1.8× 26 0.2× 21 0.3× 21 720
Kuanhui Xiang China 14 273 0.6× 246 0.9× 116 0.6× 95 0.5× 12 0.2× 33 509
Jennifer E. Vela United States 17 296 0.7× 139 0.5× 931 4.8× 317 1.8× 44 0.7× 19 1.2k

Countries citing papers authored by George Hill

Since Specialization
Citations

This map shows the geographic impact of George Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Hill more than expected).

Fields of papers citing papers by George Hill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Hill. The network helps show where George Hill may publish in the future.

Co-authorship network of co-authors of George Hill

This figure shows the co-authorship network connecting the top 25 collaborators of George Hill. A scholar is included among the top collaborators of George Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Hill. George Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Matthew D., George Hill, Beverly L. Davidson, et al.. (2025). Transcriptomic Insights into Gas6-Induced Placental Dysfunction: Gene Targets for Preeclampsia Therapy. Cells. 14(4). 278–278. 1 indexed citations
2.
Hill, George, Hong Gao, Rui Zhang, et al.. (2025). Pharmacokinetics and Safety Study of HN0141, a Novel Anti‐Human Cytomegalovirus Inhibitor, in Healthy Volunteers. Clinical Pharmacology in Drug Development. 14(9). 680–687.
3.
Kao, Jia‐Horng, Shui‐Yi Tung, Satawat Thongsawat, et al.. (2016). Ritonavir‐boosted danoprevir plus peginterferon alfa‐2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis. Journal of Gastroenterology and Hepatology. 31(10). 1757–1765. 6 indexed citations
4.
Zargaran, David, et al.. (2014). 113 Sphygmomanometer Cuffs: A Potential Source of Infection!. Heart. 100(Suppl 3). A65.1–A65. 2 indexed citations
5.
Zargaran, David, et al.. (2014). Sphygmomanometer Cuffs. Angiology. 66(2). 118–121. 10 indexed citations
6.
Nelson, David R., Stefan Zeuzem, Pietro Andreoné, et al.. (2012). Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patients( ). Annals of Hepatology. 11(1). 15–31. 41 indexed citations
7.
Zeuzem, Stefan, David R. Nelson, Pietro Andreoné, et al.. (2010). 778 PHASE IIB STUDY OF BALAPIRAVIR (RG1626; NUCLEOSIDE ANALOGUE INHIBITOR OF HCV POLYMERASE) PLUS PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN FOR CHC GENOTYPE 1: FINAL RESULTS. Journal of Hepatology. 52. S302–S303. 8 indexed citations
8.
Pockros, Paul J., David R. Nelson, Eliot Godofsky, et al.. (2008). R1626 plus peginterferon Alfa‐2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin†. Hepatology. 48(2). 385–397. 74 indexed citations
9.
Roberts, Stuart K., Graham Cooksley, Gregory J. Dore, et al.. (2008). Robust antiviral activity of R1626, a novel nucleoside analog. Hepatology. 48(2). 398–406. 87 indexed citations
10.
Lalezari, Jacob, Edward Gane, M. Rodríguez‐Torres, et al.. (2008). 66 POTENT ANTIVIRAL ACTIVITY OF THE HCV NUCLEOSIDE POLYMERASE INHIBITOR R7128 WITH PEG-IFN AND RIBAVIRIN: INTERIM RESULTS OF R7128 500MG BID FOR 28 DAYS. Journal of Hepatology. 48. S29–S29. 52 indexed citations
11.
Brandl, Michael, Xiaoyang Wu, Hong Lei, et al.. (2008). Physicochemical Properties of the Nucleoside Prodrug R1626 Leading to High Oral Bioavailability. Drug Development and Industrial Pharmacy. 34(7). 683–691. 29 indexed citations
12.
Nelson, Daniel, Paul J. Pockros, Eliot Godofsky, et al.. (2008). 993 HIGH END-OF-TREATMENT RESPONSE (84%) AFTER 4 WEEKS OF R1626, PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN FOLLOWED BY A FURTHER 44 WEEKS OF PEGINTERFERON ALFA-2A AND RIBAVIRIN. Journal of Hepatology. 48. S371–S371. 23 indexed citations
13.
Schentag, Jerome J., George Hill, Tom Chu, & Craig R. Rayner. (2007). Similarity in Pharmacokinetics of Oseltamivir and Oseltamivir Carboxylate in Japanese and Caucasian Subjects. The Journal of Clinical Pharmacology. 47(6). 689–696. 38 indexed citations
14.
Roberts, S., Graham Cooksley, David Shaw, et al.. (2006). 731 Interim results of a multiple ascending dose study of R1626, a novel nucleoside analog targeting hcv polymerase in chronic HCV patients. Journal of Hepatology. 44. S269–S269. 36 indexed citations
15.
Huang, Yue, Susanne Ostrowitzki, George Hill, et al.. (2005). Single‐ and Multiple‐Dose Pharmacokinetics of Levovirin Valinate Hydrochloride (R1518) in Healthy Volunteers. The Journal of Clinical Pharmacology. 45(5). 578–596. 12 indexed citations
16.
Oo, Charles, George Hill, Albert Dorr, et al.. (2003). Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1?5�years. European Journal of Clinical Pharmacology. 59(5-6). 411–415. 52 indexed citations
17.
Hill, George, Tomáš Cihlář, Charles Oo, et al.. (2002). The Anti-Influenza Drug Oseltamivir Exhibits Low Potential to Induce Pharmacokinetic Drug Interactions via Renal Secretion—Correlation of in Vivo and in Vitro Studies. Drug Metabolism and Disposition. 30(1). 13–19. 99 indexed citations
18.
Oo, Charles, Joanne Barrett, George Hill, et al.. (2001). Pharmacokinetics and Dosage Recommendations for an Oseltamivir Oral Suspension for the Treatment of Influenza in Children. Pediatric Drugs. 3(3). 229–236. 67 indexed citations
19.
Hill, George, et al.. (2000). Acute myocardial infarction at a university hospital: effect of race on short-term mortality.. PubMed. 11(4). 50–4. 2 indexed citations
20.
Hill, George, et al.. (1972). Phase II study of carbestrol (NSC-19962) in patients with solid tumors.. PubMed. 56(5). 641–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hwa-ping Feng Breakdown of academic impact, for papers by Yeojin Park Breakdown of academic impact, for papers by Gong Shen Breakdown of academic impact, for papers by Gitanjali Subramanya Breakdown of academic impact, for papers by Pascale Dehertogh Breakdown of academic impact, for papers by Daniel González de Requena Breakdown of academic impact, for papers by Steven Olsen Breakdown of academic impact, for papers by Katia Alves Breakdown of academic impact, for papers by Kuanhui Xiang Breakdown of academic impact, for papers by Jennifer E. Vela
Rankless by CCL
2026